Orizuru Therapeutics

Orizuru Therapeutics is a Japanese biopharmaceutical company focused on the research and development of iPSC-derived regenerative medicine. OZTx aims to implement cell therapy products and innovative iPS cell-related technologies (platform innovation) in society. It is currently utilizing iPSC-derived cardiomyocytes and islet cells for the R&D of regenerative medicine. Through collaboration with commercial partners and academic institutions, OZTx supports the commercialization of candidate seeds.